Author: contributor
-
Roche lung cancer drug success adds to pressure on Bristol
By Ben Hirschler COPENHAGEN (Reuters) – Lung cancer patients on Roche’s immune system-boosting drug Tecentriq lived on average 4.2 months longer than those taking chemotherapy in a pivotal study, pressuring Bristol-Myers Squibb’s dominant position in the field. The trial involved second-line patients, who have already used chemotherapy, and it found the Roche drug worked even…
-
Far from Hurricane Matthew, a Haitian crisis flares in Tijuana
By Lizbeth Diaz TIJUANA, Mexico (Reuters) – The havoc wreaked by Hurricane Matthew has strengthened the resolve of thousands of Haitians stuck on the U.S.-Mexico border to make it to the United States even though new rules mean they will likely be deported to their shattered homeland. A surge in the number of Haitians seeking…
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan to pay $465 million over EpiPen Medicaid rebate dispute
Mylan NV on Friday said it will pay $465 million to settle questions of whether it underpaid U.S. government healthcare programs by misclassifying its EpiPen emergency allergy treatment, which has come under intense scrutiny after a series of drastic price increases. Mylan has been lambasted by consumers and lawmakers for raising prices on the lifesaving…
-
Mylan pays $465 million to settle EpiPen Medicaid rebate dispute
(Reuters) – Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. The company has come under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade,…
-
Mylan pays $465 million to settle EpiPen Medicaid rebate dispute
(Reuters) – Mylan NV on Friday said it will pay $465 million to settle the question of whether misclassification of its EpiPen emergency allergy treatment resulted in underpayment of rebates to the U.S. Medicaid healthcare program. The company has come under scrutiny for raising prices on the lifesaving EpiPen sixfold in less than a decade,…
-
Berlusconi has heart check-up in U.S., misses trial hearing: lawyers
Former Italian prime minister Silvio Berlusconi has flown to the United States for tests on his heart condition, meaning he could not attend the start of a new trial on Monday tied to his “bunga bunga” parties, his lawyers said. The lawyers said Berlusconi had checked into the Presbyterian Columbia University Medical Center in New…
-
Jewel thieves put gun to Kim Kardashian’s head, tie her up in Paris bathroom
By Leigh Thomas PARIS (Reuters) – Masked men put a gun to reality TV star Kim Kardashian's temple, left her tied up in the bathroom of her luxury residence in Paris and stole millions of dollars' worth of jewelry in the early hours of Monday, police and her publicist said. Kardashian, wife of rapper Kanye…
-
Greek police fire teargas at pensioners during Athens protest
Greek police on Monday fired teargas to control a demonstration of pensioners protesting over cutbacks to their benefits, part of an austerity drive dictated by international lenders. About 1,500 pensioners attempted to march to Prime Minister Alexis Tsipras’s office. Riot police blocked their path.